CYTX - Cytori Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,41111,38011,659
Cost of Revenue1,3182,1703,186
Gross Profit5,0939,2108,473
Operating Expenses
Research Development11,67816,19719,000
Selling General and Administrative11,18712,1744,759
Non Recurring1,6861,6861,686
Total Operating Expenses25,776--
Operating Income or Loss-20,683-19,706-15,286
Income from Continuing Operations
Total Other Income/Expenses Net46252-79
Earnings Before Interest and Taxes-20,637-19,454-15,365
Interest Expense2,0492,5923,379
Income Before Tax-22,686-22,046-18,744
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-22,686-22,046-19,004
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-22,686-22,046-18,744
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-26,663-22,046-19,405